Hopper K D, Houts P S, TenHave T R, Matthews Y L, Colon E, Haseman D B, Hartzel J
Department of Radiology, Pennsylvania State University, Hershey 17033.
AJR Am J Roentgenol. 1994 Mar;162(3):531-5. doi: 10.2214/ajr.162.3.8109491.
A common reason given for not obtaining informed consent before the use of IV contrast material is that the anxiety created by informing patients of potential reactions will increase the possibility of their occurring. However, the idea that this is possible is debatable, and no study of this subject has used a standardized anxiety index. Accordingly, using the State-Trait Anxiety Inventory, we assessed the anxiety level among patients about to have an IV contrast procedure and measured the effect of informing them of the risks associated with the use of contrast material.
Approximately 2050 adult outpatients at three separate medical centers were solicited for participation in this study. Each of the 1251 patients who volunteered to participate was placed into one of six groups. The majority were patients who were awaiting the injection of either ionic or nonionic contrast material and who were or were not informed of the risks associated with the use of IV contrast material. The last two groups were generally healthy outpatients reporting for routine X-rays who were not awaiting IV contrast administration but who were informed of the risks associated with the use of ionic and nonionic contrast material. Each patient informed of the risks was asked to read a standardized consent form, and all patients completed a standardized anxiety index.
Patients who were informed of the risks associated with IV contrast material did not have measurably increased anxiety, and they did not have an increased prevalence of adverse reactions. Indeed, the only patients who had statistically significant increased anxiety compared with the other groups were among those awaiting the injection of ionic contrast material who were not informed of the risks (p = .04). The majority (51-78%) of patients in all six groups had measurable elevated anxiety scores.
We conclude that it is not justified to fail to obtain informed consent in order to avoid anxiety-induced adverse reactions to IV contrast material. The majority of patients awaiting injection of IV contrast material have measurable increased anxiety levels regardless of whether they are informed of its risks.
在使用静脉造影剂之前未获得知情同意的一个常见理由是,告知患者潜在反应会引发焦虑,从而增加这些反应发生的可能性。然而,这种说法是否成立存在争议,且尚无关于该主题的研究使用标准化焦虑指数。因此,我们使用状态 - 特质焦虑量表,评估即将接受静脉造影检查的患者的焦虑水平,并衡量告知他们造影剂使用相关风险的效果。
在三个不同的医疗中心招募了约2050名成年门诊患者参与本研究。自愿参与的1251名患者被分为六组。大多数患者正在等待注射离子型或非离子型造影剂,且被告知或未被告知静脉造影剂使用相关风险。最后两组是前来进行常规X光检查的一般健康门诊患者,他们不等待静脉造影剂注射,但被告知离子型和非离子型造影剂使用相关风险。每位被告知风险的患者都被要求阅读一份标准化同意书,所有患者均完成一份标准化焦虑指数评估。
被告知静脉造影剂使用相关风险的患者焦虑水平并未显著增加,不良反应发生率也未升高。实际上,与其他组相比,焦虑水平在统计学上有显著升高的唯一一组患者是那些等待注射离子型造影剂且未被告知风险的患者(p = 0.04)。所有六组中的大多数患者(51 - 78%)焦虑评分均有显著升高。
我们得出结论,为避免因焦虑引起的静脉造影剂不良反应而不获取知情同意是不合理的。大多数等待注射静脉造影剂的患者,无论是否被告知风险,焦虑水平都会显著升高。